Report
Valens Research

APD - Embedded Expectations Analysis - 2020 02 14

 Air Products and Chemicals, Inc. (APD:USA) currently trades near historical highs relative to UAFRS-based (Uniform) Assets, with a 2.6x Uniform P/B, implying bullish expectations for the firm. However, management may be concerned about the potential of their Jazan joint venture, EBITDA growth, and industrial production declines
 Specifically, management may be concerned about the progress and potential profitability of their Jazan joint venture, the capital-intensive nature of their acquired power plant assets, and the positive reception of their acquisition announcement. In addition, they may lack confidence in their ability to sustain EBITDA and EPS growth and maintain free cash flow and pricing performance. Furthermore, they may be exaggerating their focus on environmental issues, and they may be downplaying concerns about industrial production declines. Finally, they may be concerned about the progress of their YK Group project discussions and about the negative impact of their India contract modification
Underlying
Air Products and Chemicals Inc.

Air Products and Chemicals serves customers globally with a portfolio of products, services, and solutions that include atmospheric gases, process and other gases, equipment, and services. The company is a supplier of hydrogen and is engaged in helium and liquefied natural gas (LNG) process technology and equipment. The company also develops, engineers, builds, owns and operates industrial gas projects, including gasification projects that convert abundant natural resources into syngas for the production of power, fuels and chemicals. The company designs and manufactures equipment for air separation, hydrocarbon recovery and purification, LNG, and liquid helium and liquid hydrogen transport and storage.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch